In basal cancer cells, enrichment of EMT coincided with increased immune response, KRAS signaling, apoptosis and angiogenesis, and decreased oxidative phosphorylation (OXPHOS), myc targets and E2F targets with age (Fig. 3a–e). The gene discussed is KRAS; the disease is cancer.